Halozyme Therapeutics Inc. Common Stock vs Direxion Daily Semiconductor Bull 3X Shares — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Direxion Daily Semiconductor Bull 3X Shares trades at $139.76 (market cap $24.42B). The key difference: Direxion Daily Semiconductor Bull 3X Shares is the larger of the two by market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Direxion Daily Semiconductor Bull 3X Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Direxion Daily Semiconductor Bull 3X Shares for 15 Days on average.
| HALO | SOXL | |
|---|---|---|
Market Cap | $12.58B | $24.42B |
Volume | 2,179,278 | 100,232,380 |
Sector | Health | Leveraged / Inverse |
52-Week High | $115.22 | $300.77 |
52-Week Low | $61.63 | $30.81 |
Typical Hold Time | 1 Days | 15 Days |
Enterprise Value | $14.49B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SOXL, the Direxion Daily Semiconductor Bull 3X ETF, is trading at $142.52, down 10.31% in the last 24 hours amid a bearish technical signal. The leveraged ETF faces volatility from semiconductor sector swings, with mixed sentiment from news coverage. Key support sits at $134 with resistance at $145. The fund's performance is directly tied to the Philadelphia Semiconductor Index, which recently hit a three-month high, highlighting the sector's inherent volatility.
The outlook for SOXL is highly speculative, offering amplified exposure to semiconductor cyclicality. Investment opportunity lies in strong AI-driven chip demand, but risks are severe due to the 3x leverage, regulatory headwinds, and crowded trading. Investors face potential for sharp gains or losses based on semiconductor market timing.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →SOXL is a leveraged ETF that seeks daily investment results corresponding to 300% of the daily performance of the ICE Semiconductor Index. It is designed as a tactical tool for experienced traders to take a bullish (long) position on the semiconductor sector. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment.
Read more on SOXL →